SCHEMBL899259

SCHEMBL899259

CCOCCN1C=CN(C)C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29285460 0.98 CYP2D6 (0.32) ALDH1A1
Bromide SCHEMBL2760789 0.98 ALDH1A1 (0.30) ALDH1A1
SCHEMBL2520925 0.88 ALDH1A1 (0.31) ALDH1A1
SCHEMBL2519182 0.86
SCHEMBL17419021 0.83 ALDH1A1 (0.31) ALDH1A1
Methoxyacetic Acid SCHEMBL28005633 0.83 CYP2D6 (0.31)
SCHEMBL28005357 0.83 ALDH1A1 (0.32) ALDH1A1
SCHEMBL28136225 0.82 TSHR (0.38) ALDH1A1
Hydrochloric Acid SCHEMBL28363475 0.82 CYP2D6 (0.32) ALDH1A1
SCHEMBL899049 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117338748-B Capsule for treating atrial and ventricular premature beat and its preparing process 泉州雷恩生化有限公司 2024-04-05 CN claimed
CN-114409599-A Preparation method of ether-based functional ionic liquid 辽宁大学 2022-04-29 CN claimed
US-8921589-B2 Electrolyte formulations MERCK PATENT GMBH (DE) 2014-12-30 US claimed
US-8864883-B2 Surface treatments for dessicant media in a water recovery device Z124 (KY) 2014-10-21 US claimed
US-8829201-B2 Electrolyte Formulations MERCK PATENT GMBH (DE) 2014-09-09 US claimed
US-8808424-B2 Apparatus and method for removing CO2 from a production plant discharge MUNTERS CORPORATION (US) 2014-08-19 US claimed
EP-2673068-A1 Apparatus and method for removing co2 from a production plant discharge Munters Corporation (US) 2013-12-18 EP claimed
US-20130319022-A1 SURFACE TREATMENTS FOR DESSICANT MEDIA IN A WATER RECOVERY DEVICE Z124 (KY) 2013-12-05 US claimed
US-20120318360-A1 Electrolyte Formulations MERCK PATENT GMBH (DE) 2012-12-20 US claimed
US-20120204717-A1 APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE MUNTERS CORPORATION (US) 2012-08-16 US claimed
WO-2012109547-A1 APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE MUNTERS CORPORATION (US) 2012-08-16 WO claimed
US-20110247494-A1 LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS VTU Holding GmbH. (AT) 2011-10-13 US claimed
US-20250122323-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-04-17 US disclosed
US-20250122322-A1 ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-04-17 US disclosed
CN-118324698-A Imidazole phosphinate ionic liquid and preparation method and application thereof 华南理工大学 2024-07-12 CN disclosed
CN-117946544-A Graphene premix, coating composition, and coated article 宣伟(南通)涂料有限公司 2024-04-30 CN disclosed
WO-2011085965-A1 ELECTROLYTE FORMULATIONS MERCK PATENT GMBH (DE) 2011-07-21 WO disclosed
WO-2011085964-A1 ELECTROLYTE FORMULATIONS MERCK PATENT GMBH (DE) 2011-07-21 WO disclosed
WO-2011085967-A1 COMPOUNDS CONTAINING PERFLUOROALKYL-CYANO-ALKOXY-BORATE ANIONS OR PERFLUOROALKYL-CYANO-ALKOXY-FLUORO-BORATE ANIONS MERCK PATENT GMBH (DE) 2011-07-21 WO disclosed
US-20060186419-A1 Light-emitting device KABUSHIKI KAISHA TOSHIBA (JP) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120318360-A1 Electrolyte Formulations NHERF1, HCN4, DDT ALDH1A1 1217/4885
US-20250122322-A1 ZWITTERIONIC COMPOUND, AND BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANATE COMPOSITION CONTAINING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR MANUFACTURING SAME, AND CARBONATE COMPOUND RCC1, KDM2B, RB1 ALDH1A1 2558/4885
US-20250122323-A1 ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR KDM2B, O60361, IDH3B ALDH1A1 1023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.